Melatonin Prevents the Harmful Effects of Obesity on the Brain, Including at the Behavioral Level

Mol Neurobiol. 2018 Jul;55(7):5830-5846. doi: 10.1007/s12035-017-0796-8. Epub 2017 Oct 30.

Abstract

Obesity is a health problem caused by a diet rich in energy and the sedentary lifestyle of modern societies. A leptin deficiency is one of the worst causes of obesity, since it results in morbid obesity, a chronic disease without a cure. Leptin is an adipokine secreted in a manner dependent on the circadian rhythm that ultimately reduces food intake. We studied cellular alterations in brain of leptin-deficient obese animals and tested whether these alterations are reflected in abnormal behaviors. Obesity induced increases in oxidative stress and the unfolded protein response caused by endoplasmic reticulum stress. However, the subsequent signaling cascade was disrupted, blocking possible systemic improvements and increasing the production of misfolded proteins that trigger autophagy. Up-regulated autophagy was not indefinitely maintained and misfolded proteins accumulated in obese animals, which led to aggresome formation. Finally, neurodegenerative markers together with anxiety and stress-induced behaviors were observed in leptin-deficient mice. As oxidative stress has an essential role in the development of these harmful effects of obesity, melatonin, a powerful antioxidant, might counteract these effects on the brain. Following treatment with melatonin, the animals' antioxidant defenses were improved and misfolded protein, proteasome activity, and autophagy decreased. Aggresome formation was reduced due to the reduction in the levels of misfolded proteins and the reduction in tubulin expression, a key element in aggresome development. The levels of neurodegenerative markers were reduced and the behaviors recovered. The data support the use of melatonin in therapeutic interventions to reduce brain damage induced by leptin deficiency-dependent obesity.

Keywords: Aggresome; Brain; Brain damage; Leptin deficiency; Melatonin; Obesity.

MeSH terms

  • Animals
  • Autophagy / drug effects
  • Behavior, Animal / drug effects*
  • Biomarkers / metabolism
  • Body Weight / drug effects
  • Brain / drug effects
  • Brain / pathology*
  • Cytokines / metabolism
  • Endoplasmic Reticulum Stress / drug effects
  • Inflammation Mediators / metabolism
  • Leptin / deficiency
  • Leptin / metabolism
  • Male
  • Melatonin / pharmacology
  • Melatonin / therapeutic use*
  • Mice, Inbred C57BL
  • Nerve Degeneration / pathology
  • Obesity / drug therapy*
  • Obesity / pathology
  • Organ Size / drug effects
  • Oxidative Stress / drug effects
  • Proteasome Endopeptidase Complex / metabolism
  • Ubiquitin / metabolism

Substances

  • Biomarkers
  • Cytokines
  • Inflammation Mediators
  • Leptin
  • Ubiquitin
  • Proteasome Endopeptidase Complex
  • Melatonin